Jeffrey Ro PullenUnion Center, NJ

Jeffrey Pullen Phones & Addresses

Union, NJ

Work

Company: General moving carrier - Maplewood, NJ Aug 2013 Position: Carrier

Education

School / High School: tully house community education center- Newark, NJ 2011 Specialities: none in none

Skills

Heavy equipment opportrator • Landscaper • Painter • Furniture mover • and all around handy man.I've also obtained my Serv Safe where i have learned how to food prep • help run salad an sandwitch stations • and been a dishwasher at a local restaurant. I know how to make certain desserts • and i also know how to listen and become a great team member.

Mentions for Jeffrey Ro Pullen

Jeffrey Pullen resumes & CV records

Resumes

Jeffrey Pullen Photo 35

Jeffrey Pullen

Jeffrey Pullen Photo 36

Truck Driver

Work:
Shneider National
Truck Driver
Jeffrey Pullen Photo 37

Jeffrey C Pullen

Jeffrey Pullen Photo 38

Jeffrey Pullen

Jeffrey Pullen Photo 39

Jeffrey Pullen - Rock Hill, SC

Work:
general moving carrier - Maplewood, NJ Aug 2013 to Oct 2014
carrier
General Moving Carriers - Maplewood, NJ Aug 2013 to Oct 2014
Carrier
Education:
tully house community education center - Newark, NJ 2011 to 2011
none in none
Skills:
Heavy equipment opportrator, Landscaper, Painter, Furniture mover , and all around handy man.I've also obtained my Serv Safe where i have learned how to food prep, help run salad an sandwitch stations, and been a dishwasher at a local restaurant. I know how to make certain desserts, and i also know how to listen and become a great team member.

Publications & IP owners

Us Patents

Method For The High Level Expression, Purification And Refolding Of The Outer Membrane Group B Porin Proteins From Neisseria Meningitidis

US Patent:
6013267, Jan 11, 2000
Filed:
Feb 11, 1997
Appl. No.:
8/798760
Inventors:
Milan S. Blake - New York NY
Joseph Y. Tai - Fort Washington PA
Huilin L. Qi - New York NY
Shu-Mei Liang - Bethesda MD
Lucjan J.J. Hronowski - Laurel MD
Jeffrey K. Pullen - Columbia MD
Assignee:
North American Vaccine, Inc. - Columbia MD
The Rockefeller University - New York NY
International Classification:
A61K 39095
US Classification:
4242491
Abstract:
The present invention relates, in general, to a method for the high level expression of the outer membrane protein meningococcal group B porin proteins and fusion proteins thereof. In particular, the present invention relates to a method of expressing the outer membrane protein meningococcal group B porin proteins in E. coli wherein the meningococcal group B porin proteins and fusion proteins thereof comprise more than 2% of the total protein expressed in E. coli. The invention also relates to a method of purification and refolding of the meningococcal group B porin proteins and fusion proteins thereof and to their use in vaccines.

Method For The High Level Expression, Purification And Refolding Of The Outer Membrane Group B Porin Proteins From Neisseria Meningitidis

US Patent:
5439808, Aug 8, 1995
Filed:
Jul 23, 1993
Appl. No.:
8/096182
Inventors:
Milan S. Blake - New York NY
Joseph Y. Tai - Fort Washington PA
Huilin L. Qi - New York NY
Shu-Mei Liang - Bethesda MD
Lucjan J. J. Hronowski - Laurel MD
Jeffrey K. Pullen - Columbia MD
Assignee:
North American Vaccine, Inc. - Beltsville MD
The Rockefeller University - New York NY
International Classification:
C12N 1531
C12N 1562
C12N 1567
C12N 1570
US Classification:
435 691
Abstract:
The present invention relates, in general, to a method for the high level expression of the outer membrane protein meningococcal group B porin proteins and fusion proteins thereof. In particular, the present invention relates to a method of expressing the outer membrane protein meningococcal group B porin proteins in E. coli wherein the meningococcal group B porin proteins yard fusion proteins thereof comprise more than 2% of the total protein expressed in E. coli. The invention also relates to a method of purification and refolding of the meningococcal group B porin proteins and fusion proteins thereof and to their use in vaccines.

Method For The High Level Expression, Purification And Refolding Of The Outer Membrane Group B Porin Proteins From Neisseria Meningitidis

US Patent:
5747287, May 5, 1998
Filed:
Jun 17, 1997
Appl. No.:
8/877109
Inventors:
Milan S. Blake - New York NY
Joseph Y. Tai - Fort Washington PA
Huilin L. Qi - New York NY
Shu-Mei Liang - Bethesda MD
Lucjan J. J. Hronowski - Laurel MD
Jeffrey K. Pullen - Columbia MD
Assignee:
North American Vaccine, Inc. - Beltsville MD
The Rockefeller University - New York NY
International Classification:
C07K 100
C12P 2106
C12N 1500
A61K 3905
US Classification:
435 691
Abstract:
The present invention relates, in general, to a method for the high level expression of the outer membrane protein meningococcal group B porin proteins and fusion proteins thereof. In particular, the present invention relates to a method of expressing the outer membrane protein meningococcal group B porin proteins in E. coli wherein the meningococcal group B porin proteins and fusion proteins thereof comprise more than 2% of the total protein expressed in E. coli. The invention also relates to a method of purification and refolding of the meningococcal group B porin proteins and fusion proteins thereof and to their use in vaccines.

Method For The High Level Expression, Purification And Refolding Of The Outer Membrane Group B Porin Proteins From Neisseria Meningitidis

US Patent:
5879686, Mar 9, 1999
Filed:
May 8, 1997
Appl. No.:
8/853504
Inventors:
Milan S. Blake - New York NY
Joseph Y. Tai - Fort Washington PA
Huilin L. Qi - New York NY
Shu-Mei Liang - Bethesda MD
Lucjan J. J. Hronowski - Laurel MD
Jeffrey K. Pullen - Columbia MD
Assignee:
North American Vaccine, Inc. - Beltsville MD
The Rockefeller University - New York NY
International Classification:
A61K 39095
US Classification:
4242491
Abstract:
The present invention relates, in general, to a method for the high level expression of the outer membrane protein meningococcal group B porin proteins and fusion proteins thereof. In particular, the present invention relates to a method of expressing the outer membrane protein meningococcal group B porin proteins in E. coli wherein the meningococcal group B porin proteins and fusion proteins thereof comprise more than 2% of the total protein expressed in E. coli. The invention also relates to a method of purification and refolding of the meningococcal group B porin proteins and fusion proteins thereof and to their use in vaccines.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.